Autoimmune diabetes: The role of T cells, MHC molecules and autoantigens

Autoimmunity

Volumn 27, Issue 3, 1998, Pages 159-177

  Durinovic Bello, Ivana ^a  

^a Klinikum Schwabing   (Germany)

Author keywords

Diabetes (IDDM); Human leukocyte antigen (HLA); Major histocompatibility complex (MHC); T cells; cell autoantigens

Indexed keywords

AUTOANTIGEN; EPITOPE; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE;

AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; REVIEW; T LYMPHOCYTE;

EID: 0031959942     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809003864     Document Type: Review

References (146)

1. Liblau, R. S., Singer, S. M. and McDevitt, H. O. (1995). Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today, 16, 34-8.
2. Scott, P. (1993). Selective differentiation of CD4+ T-helper cell subsets. Curr Opin Immunol, 5, 391-7.
3. Zinkernagel, R. M. (1996). Immunology taught by viruses. Science, 271, 173-8.
4. Mandrup-Poulsen, T. (1996). The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia, 39, 1005-29.
5. Naquet, P., Ellis, J., Tibensky, D., Kenshole, A., Singh, B. and Hodges, R., et al. (1988). T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J. Immunol, 140, 2569-78.
6. Harrison, L. C., Chu, S. X., DeAizpurua, H. J., Graham, M., Honeyman, M. C. and Colman, P. G. (1992). Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J. Clin. Invest., 89, 1161-5.
7. Roep, B. O. (1996). T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes, 45, 1147-56.
8. Durinovic Bello, I., Steinle, A., Ziegler, A. G. and Schendel, D. J. (1994). HLA-DQ-restricted, islet-specific T-cell clones of a type 1 diabetic patient. T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes, 43, 1318-25.
9. Durinovic Bello, I., Hummel, M. and Ziegler, A. G. (1996). Cellular immune response to diverse islet cell antigens in IDDM. Diabetes, 45, 795-800.
10. Eisenbarth, G. S. and Ziegler, A. G. (1995). Type 1 diabetes mellitus, In: Molecular Endocrinology: Basic Concepts and Clinical Correlations. Weintraub, B. D. (ed), New York, Raven Press, 269-82.
11. Itoh, N., Hanafusa, T., Miyazaki, A., Miyagawa. J., Yamagata, K., Yamamoto, K., et al. (1993). Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest., 92, 2313-22.
12. Sibley, R. K., Sutherland, D. E., Goetz, F. and Michael, A. F. (1985). Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest., 53, 132-44.
13. Like, A. A., Biron, C. A., Weringer, E. J., Byman, K., Sroczynski, E. and Guberski, D. L. (1986). Prevention of diabetes in Bio-Breeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J. Exp. Med., 164, 1145-59.
14. Kröncke, K. D., Funda, J., Berschick, B., Kolb, H. and Kolb Bachofen, V. (1991). Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are beta-cell specific. Diabetologia, 34, 232-8.
15. Rabinovitch, A., Suarez-Pinzon, W. L. and Sorensen, O. (1996). Interleukin 12 mRNA expression in islets correlates with β-cell destruction in NOD mice. J. Autoimmun, 9, 645-51.
16. Bendelac, A., Carnaud, C., Boitard, C. and Bach, J. F. (1987). Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J. Exp. Med., 166, 823-32.
17. Wang, B., Gonzalez, A., Benoist, C. and Mathis, D. (1996). The role of CDS+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol., 26. 1762-9.
18. Katz, J., Benoist, C. and Mathis, D. (1993). Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol., 23, 3358-60.
19. Todd, J. A., Bell, J. I. and McDevitt, H. O. (1987). HLADQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature, 329, 599-604.
20. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S. and Strominger, J. L. (1993). Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles, J. Exp. Med., 178, 27-47.
21. Baum, H., Davies, H. and Peakman, M. (1996). Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol. Today, 17, 68-70.
22. Tisch, R. and McDevitt, H. (1996). Insulin-dependent diabetes mellitus. Cell, 85, 291-7.
23. Cudworth, A. G. (1978). Type I diabetes mellitus. Diahetologia, 14, 281-91.
24. Durinovic-Bello, I., Kadrnka-Lovrencic, M., Frleta, M., Balog, V., Dumic, M. and Kalaftic, Z., et al. (1979). HLA antigens in families of patients with insulin-dependent diabetes mellitus. Period. Biol., 81, 205.
25. Todd, J. A., Bell, J. I. and McDevitt, H. O. (1988). HLA antigens and insulin-dependent diabetes. Nature, 333, 710.
26. Tuomilehto Wolf, E., Tuomilehto, J., Cepaitis, Z. and Lounamaa, R. (1989). New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet, 2, 299-302.
27. Kelly, H., McCann, V. J., Kay, P. H. and Dawkins, R. L. (1985). Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles. Immunogenetics, 22, 643-51.
28. Durinovic Bello, I., Schendel, D. J., Kastelan, A. and Segurado, O. G. (1993). A novel diabetes-susceptibility HLA haplotype is present in the Croatian population. Tissue Antigens., 41, 107-9.
29. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L. et al. (1993). Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 [see comments]. Nature, 364, 33-9.
30. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. et al. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature, 368, 215-21.
31. Jardetzky, T. S., Gorga, J. C, Busch, R., Rothbard, J., Strominger, J. L. and Wiley, D. C. (1990). Peptide binding to HLA-DR1 : a peptide with most residues substituted to alanine retains MHC binding. EMBO J., 9, 1797-803.
32. Rammensee, H. G., Friede, T. and Stevanovic, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228.
33. Ronningen, K. S., et al. (1993). HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids and Japanese. In: HLA 1991. Vol. 1. Tsuji, K., Aitawa, M., Sasazuki. T. (eds.). Oxford, U.K., Oxford Science Publications, 713-22.
34. Khalil, I., et al. (1993). A restricted number of HLA-DQα/β heterodimers confer varying degrees of susceptibility to insulin-dependent diabetes mellitus. In: HLA 1991. Vol. 1. Tsuji, K., Aitawa, M., Sasazuki, T. (eds.). Oxford, U.K., Oxford Science Publications, 483-492.
35. Hammer, J., Gallazzi, F., Bono, E., Karr, R. W., Guenot, J., Valsasnini, P., et al. (1995). Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med., 181, 1847-55.
36. Wucherpfennig, K. W., Yu, B., Bhol, K., Monos, D. S., Argyris, E., Karr. R. W., et al. (1995). Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of selfpeptides in pemphigus vulgaris. Proc. Natl. Acad. Sci. U.S.A., 92, 11935-9.
37. Reich, E. P., von Grafenstein, H., Barlow, A., Swenson, K. E., Williams, K. and Janeway, C. A. J. (1994). Self peptides isolated from MHC glycoproteins of nonobese diabetic mice. J Immunol., 152, 2279-88.
38. Böhme, J., Schuhbaur, B., Kanagawa, O., Benoist, C. and Mathis, D. (1990). MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science, 249, 293-5.
39. Thorsby, E. and Ronningen, K. S. (1993). Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 36, 371-7.
40. Kwok, W. W., Domeier, M. E., Raymond, F. C., Byers, P. and Nepom, G. T. (1996). Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol., 156, 2171-7.
41. Tienari, P. J., Tuomilehto-Wolf, E. and Peltonen, L. (1992). DIME Study Group. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. Diabetologia, 35, 254-60.
42. Fennessy, M., Metcalfe, K., Hitman, G. A., Niven, M., Biro, P. A., Tuomilehto, J., et al. (1994). A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia, 37, 937-44.
43. Demaine, A. G., Hibberd, M. L., Mangles, D. and Millward, B. A. (1995). A new marker in the HLA class I region is associated with the age at onset of IDDM. Diabetologia, 38, 623-8.
44. Ikegami, H., Kawaguchi, Y., Ueda, H., Fukuda, M., Takakawa, K., Fujioka, Y., et al. (1993). MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3' boundary of the diabetogenic region. Biochem. Biophys. Res. Commun., 192, 677-82.
45. Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson, E., Fischer, P. A., et al. (1994). Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes, 43, 500-4.
46. Lehmann, P. V., Forsthuber, T., Miller, A. and Sercarz, E. E. (1992). Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature, 358, 155-7.
47. Böhmer, K., Keilacker, H., Kuglin, B., Hubinger, A., Bertrams, J., Gries, F. A., et al. (1991). Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia, 34, 830-4.
48. Drell, D. W. and Notkins, A. L. (1987). Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 30, 132-43.
49. Castano, L., Russo, E., Zhou, L., Lipes, M. A. and Eisenbarth, G. S. (1991). Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J. Clin. Endocrinol. Metab., 73, 1197-201.
50. Baekkeskov, S., Aanstoot, H. J., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., et al. (1990). Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature, 347, 151-6.
51. Pietropaolo, M., Castano, L., Babu, S., Buelow, R., Kuo, Y. L., Martin, S., et al. (1993). Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest., 92, 359-71.
52. Lan, M. S., Lu, J., Goto, Y. and Notkins, A. L. (1994). Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol., 13, 505-14.
53. Notkins, A. L., Lu, J., Qing, L., VanderVegt, F. P., Wasserfall, C., Maclaren, N. K. and Lan, M. S. (1996). IA-2 and IA-2β are major autoantigens in IDDM and the precursors of the 40 kDa and 37 kDa tryptic fragments. J. Autoimm., 9, 677-82.
54. Hawkes, C. J., Wasmeier, C., Christie, M. R. and Hutton, J. C. (1996). Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes, 45, 1187-92.
55. Aanstoot, H. J., Kang, S. M., Kim. J., Lindsay, L. A., Roll, U., Knip, M., et at. (1996). Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J. Clin. Invest., 97, 2772-83.
56. Christie, M. R., Hollands, J. A., Brown, T. J., Michelsen, B. K. and Delovitch, T. L. (1993). Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J. Clin. Invest., 92, 240-8.
57. Boitard, C., Villa, M. C., Becourt, C., Gia, H. P., Hue, C, Sempe, P., et al. (1992). Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc. Natl. Acad. Sci. U.S.A., 89, 172-6.
58. Arden, S. D., Roep, B. O., Neophytou, P. I., Usac, E. F., Duinkerken, G., de Vries, R. R., et al. (1996) Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J. Clin. Invest., 97, 551-61.
59. Honeyman, M. C., Cram, D. S. and Harrison, L. C. (1993). Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes, 42, 626-30.
60. Endl, J., Otto, H., Jung, G., Dreisbusch, B., Donie, F., Stahl, P., Elbracht, R., Schmitz, G., Meinl, E., Zieglar, A.-G., Wank, R. and Schendel, D. J. (1997). Identification of T cell epitopes of glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Exp Med, 99, 2405-15.
61. Lohmann, T., Leslie, R. D. and Londei, M. (1996). T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun., 9, 385-9.
62. Genovese, S., Bonfanti, R., Bazzigaluppi, E., Lampasona, V., Benazzi, E., Bosi. E., Chiumello, G. and Bonifacio, E. (1996). Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia, 39, 1223-6.
63. Roep, B. O., Duinkerken, G., Schreuder, G. M., Kolb, H., de Vries, R. R. and Martin, S. (1996). HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Ear. J. Immunol., 26, 1285-9.
64. Griffing, W. L., Moore, S. B., Luthra, H. S., McKenna, C. H. and Fathman, C. G. (1980). Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene. J. Exp. Med., 152, 319-25.
65. Steiner, D. F., Clark, J. L., Nolan, C., Rubenstein, A. H., Margoliash, E., Aten, B., et al. (1969). Proinsulin and the biosynthesis of insulin. Recent. Prog. Horm. Res., 25, 207-82.
66. Larger, E., Becourt, C., Bach, J. F. and Boitard, C. (1995). Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. J. Exp. Med., 181, 1635-42.
67. Keller, R. J. (1990). Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus. J. Autoimmun., 3, 321-7.
68. Schloot, N. C., Roep, B. O., Wegmann, D., Yu, L., Chase, H. P., Wang, T. and Eisenbarth, G. S. (1997). Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia, 40, 564-672.
69. Rudy, G., Brusic, V., Harrison, L. C. and Lew, A. M. (1995). Sequence similarity between beta-cell autoanti-gens. Immunol. Today, 16, 406-7.
70. Rudy, G., Stone, N., Harrison, L. C., Colman, P. G., McNair, P., Brusic, V., et al. (1995). Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med., 1, 625-33.
71. Roll, U., Christie, M. R., Fuchtenbusch, M., Payton, M. A., Hawkes, C. J. and Ziegler, A. G. (1996). Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes, 45, 967-73.
72. Kaufman, D. L., Clare Salzler, M., Tian, J., Forsthuber, T., Ting, G. S., Robinson, P., et al. (1993). Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature, 366, 69-72.
73. Wegman, D. R., Norbury-Glaser, M. and Daniel, D. (1994). Insulin-Specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol., 24, 1853-57.
74. Daniel, D. and Wegman, D. R. (1996). Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci., 93, 956-69.
75. Tompkins, S. M., Moore, J. C. and Jensen, P. E. (1996). An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med., 183, 857-66.
76. Jensen, P. E. and Kraft, A. O. (1990). T cells from nonre-sponder mice. MHC restricted and unrestricted recognition of insulin. J Immunol., 145, 3985-91.
77. Krug, U., Krug, F. and Cuatrecasas, P., et al. (1972). Emergence of insulin receptors on human lymphocytes during in vitro transformation. Proc. Natl. Acad. Sci. U.S.A., 69, 2604-8.
78. Diaz Espada, F. and Lopez Alarcon, L. (1982). Mitogen-induced changes in glycolytic enzymes of mouse lymphocytes: influence of insulin on cell activation in vitro. Immunology, 46, 705-12.
79. Helderman, J. H. and Strom, T. B. (1979). Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes. J. Biol. Chem., 254, 7203-7.
80. Strom, T. B., Bear, R. A. and Carpenter, C. B. (1975). Insulin-induced augmentation of lymphocyte-mediated cytotoxicity. Science, 187, 1206-8.
81. Bhakri, H. L., Jones, H., Jones, D. A., Pettingale, K. W. and Tee D. E. H. (1983). T cell subpopulation dynamics following insulin-induced hypoglycemia in normal subjects. Clin. Exp. Immunol., 53, 83-7.
82. Pugliese, A., Bugawan, T., Moromisato, R., Awdeh, Z. L., Alper, C. A., Jackson, R. A., et al. (1994). Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. J. Clin. Invest., 93, 2447-52.
83. Ziegler, R., Alper, C. A., Awdeh, Z. L., Castano, L., Brink, S. J., Soeldner J. S., et al. (1991). Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes. Diabetes, 40, 709-14.
84. Ziegler, A. G., Standl, E., Albert, E. and Mehnert, H. (1991). HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients. Diabetes, 40, 1146-9.
85. Tisch, R., Yang, X. D., Singer, S. M., Liblau, R. S., Fugger, L. and McDevitt, H. O. (1993). Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature, 366, 72-5.
86. Dylan, D. and Wegmann, D. R. (1996). Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. U.S.A., 93, 956-60.
87. Zhang, Z. J., Davidson, L., Eisenbarth, G. and Weiner, H. L. (1991). Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. U.S.A., 88, 10252-6
88. Tian, J., Lehmann, P. V. and Kaufman, D. L. (1994). T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med., 180, 1979-84.
89. Elliott, J. F., Qin, H.-Y., Bhatti, S., Smith, D. K., Singh, R. K., Dillon, T., et al. (1994). Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes, 43, 1494-9.
90. Atkinson, M. A., Bowman, M. A., Campbell, L., Darrow, B. L., Kaufman, D. L. and Maclaren, N. K. (1994). Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest., 94, 2125-9.
91. Lohmann, T., Leslie, R. D., Hawa, M., Geysen, M., Rodda, S. and Londei, M. (1994). Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus [see comments]. Lancet, 343, 1607-8.
92. Jones, D. B. and Crosby, I. (1996). Proliferate lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia, 39, 1318-24.
93. Bruserud, O., Jervell, J. and Thorsby, E. (1985). HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia, 28, 420-6.
94. Delamaire, M., Timsit, J., Caillat Zucman, S., Maugendre. D., Roussely, H., Semana, G., et al. (1995). HLA-associated heterogeneity of the humoral response to islet antigens in insulin-dependent diabetes. J. Autoimmun., 8, 645-57.
95. Passini, N., Larigan, J. D., Genovese, S., Appella, E., Sinigaglia, F. and Rogge, L. (1995). The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc. Natl. Acad. Sci. U.S.A., 92, 9412-6.
96. Payton, M. A., Hawkes, C. J. and Christie, M. R. (1995). Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest., 96, 1506-11.
97. Morrison, D. C. and Ryan, Y. L. (1987). Endotoxins and disease mechanisms. Ann Rev Med, 38, 417-32.
98. Gegner, J. A., et al. (1995). Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem, 270, 5320-25.
99. Christie, M. R., Genovese, S., Cassidy, D., Bosi. E., Brown, T. J., Lai, M., et al. (1994). Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes, 43, 1254-9.
100. Leslie, R. D. G. and Elliott, R. B. (1994). Perspectives in diabetes: Early environmental events as a cause of IDDM. Evidence and implications. Diabetes, 43, 843-50.
101. Fujita, T., Yui, R., Kusumoto, J., Serizawa, J., Makino, S. and Tochino, Y. (1982). Lymphocyte insulitis in NOD (non-obese diabetic) mice: an immunohistochemical and electron microscope investigation. Biochem Res, 3, 429-30.
102. Castano, L. and Eisenbarth, G. S. (1990). Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Anna. Rev. Immunol., 8, 647-79.
103. Scherbaum, W. A. and Seissler, J. (1995). Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus. Exp. Clin. Endocrinol., 103, 88-94.
104. Hummel. M., Durinovic Bello, I. and Ziegler, A. G. (1996). Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J. Autoimmun., 9, 427-30.
105. Harrison, L. C., Honeyman, M. C., De Aizpurua, H. J., et al. (1993). Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet, 341, 1365-1369.
106. Watts, C. and Lanzavecchia, A. (1993). Suppressive effect of antibody on processing of T cell epitopes. J Exp Med, 178, 1459-1463.
107. Simitsek, P. D., Campbell, D. G., Lanzavecchia, A., Fairweather, N. and Watts, C. (1995). Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med, 181, 1957-1963.
108. Lanzavecchia, A. (1995). How can cryptic epitopes trigger autoimmunity? J Exp Med, 181, 1945-1948.
109. Honeyman, M. C., Harrison, L. C., Drummond, B., Colman, P. G. and Tait, B. (1995). Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Molecular Medicine, 5, 576-582.
110. Pfeffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A. and Bottomly, K. (1995). Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med, 181, 1569-1574.
111. Pfeffer, C., Murray, J. and Bottomly, K. (1991). Selective activation of Th1 and Th2 like cells in vivo. Response to human collagen IV. Immunol Rev, 123, 65-84.
112. Dong, X., Hamilton, K. J., Satoh, M., Wang, J. and Reeves, W. H. (1994). Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med, 179, 1243-1252.
113. Davies, J. L., Kawaguchi, Y., Bennett, S. T., Copeman, J. B., Cordell, H. J., Pritchard, L. E., et al. (1994). A genome-wide search for human type 1 diabetes susceptibility genes. Nature, 371, 130-6.
114. Bennett, S. T., Lucassen, A. M., Gough, S. C. L., Powell, E. E., Undlien, D. E., Pritchard, L. E., et al. (1995). Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genetics, 9, 284-292.
115. Suzuki, T., Yamada, Y., Fujimura, T., et al. (1987). Diabetogenic effects of lymphocyte transfusion on the NOD or NOD nude mouse. In: Rygaard, J., Brunner, N., Graem, N., Spang-Thomsen, N. (eds). Immune-deficient animals in biomedical research. Karger, Basel, 112-6.
116. Oldstone, M. B. (1990). Viruses as therapeutic agents. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J. Exp. Med., 171, 2077-89.
117. Qin, H. Y., Sadelain, M. W., Hitchon, C., Lauzon, J. and Singh, B. (1993). Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol., 150, 2072-80.
118. Bach, J. F. (1994). Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapie. Clin Immunol Immunopathol, 72, 156-161.
119. Szopa, T. M., Titchener, P. A., Portwood, N. D. and Taylor, K. W. (1993). Diabetes mellitus due to viruses-some recent developments. Diabetologia, 36, 687-695.
120. Rabinowe, S. L., George, K. L., Laughlin, R., Soeldner, J. S. and Eisenbarth, G. S. (1986). Congenital rubella: monoclonal antibody defined T-cell abnormalities in young children. Am J Med, 81, 779-782.
121. Menser, M. A., Forrest, J. M. and Bransby, R. D. (1978). Rubella infection and diabetes mellitus. Lancet, 1, 57-60.
122. Ward, K. P., Galloway, W. H. and Aucherlonie, I. A. (1979). Congenital cytomegalovirus and diabetes. Lancet, I. 497-99.
123. Park, C-Y., McArthur, R. G., Eun. H.-M. and Yoon, J.-W. (1979). Cytomegalovirus infection with autoimmune type I diabetes. Lancet, I, 1-14.
124. Wagenknecht, L. E., Roseman, J. M. and Herman, W. H. (1991). Oncreased incidence of insulin dependent diabetes mellitus following an epidemic of Coxsackie B5. Am J Epidemiol, 133, 1024-1031.
125. Petersen, K. G., Heilmeyer, P. and Kerp, L. (1975). Synthesis of proinsulin and large glucagon immunoreactivity in isolated islets of Largenhans from EMC virus infected mice. Diabetologia, 11, 21-25.
126. Portwood, N. D. and Taylor, K. W. (1990). Coxsackie B4 virus-induced changes in mouse pancreatic β-cell mRNAs. Biochem Soc Trans, 18, 1264-67.
127. Parkkonen, P., Hyoty, H., Koskinen, L. and Leinikki, P. (1992). Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia, 35, 63-69.
128. Cavallo, M. G., Baroni, M. G., Toto, A., et al. (1992). Viral infection induces cytokine release by islet beta cells. Immunology, 75, 664-668.
129. Lefkovith, J., Schreiner, G., Cormier, J., Handler, E. S., Driscol, H. F., Greiner, D., et al. (1990). Prevention of diabetes in the BB rat by essential fatty acid deficiency: Relationship between physiological and biochemical changes. J Exp Med, 171, 729-743.
130. Elliot, R. B., Reddy, S. N., Bibby, N. J. and Kida, K. (1988). Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia, 31, 62-64.
131. Karges, W., Hammond-McKibben, D., Cheung, R., Visconti, M., Shibuya, N., Kemp, D., et al. (1997). Immunological aspects of nutritional diabetes pretension in NOD mice. A pilot study for the cow's milk-based IDDM prevention trial. Diabetes, 46, 557-564.
132. Zauderer, M., Campbell, H., Johnson, D. R. and Seman, M. (1984). Helper functions of antigen-induced specific and autoreactive T cell colonies. J. Mol. Cell Immunol., 1, 65-77.
133. Tilkin, A. F., Michon, J., Juy, D., Kayibanda, M., Henin, Y., Sterkers, G., et al. (1987). Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in man. J. Immunol., 138, 674-9.
134. Strober, W. and James, S. P. (1990). Immunoregulatory function of human autoreactive T-cell lines and clones. Immunol. Rev., 116, 117-38.
135. Kotani, H., Mitsuya, H., Jarrett, R. F., Yenokida, G. G., James, S. P. and Strober, W. (1986). An autoreactive T cell clone that can be activated to provide both helper and suppressor function. J Immunol., 136, 1951-9.
136. Bensussan, A., Meuer, S. C., Schlossman, S. F. and Reinherz, E. L. (1984). Delineation of an immunoregulatory amplifier population recognizing autologous la molecules. Analysis with human T cell clones. J. Exp. Med., 159, 559-76.
137. Kakkanaiah, V. H., Seth, A., Nagarkatti, M. and Nagarkatti, P. S. (1990). Autoreactive T cell clones isolated from normal and autoimmune-susceptible mice exhibit lymphokine secrectory and functional properties of both Th1 and Th2 cells. Clin, Immunol. Immunopathol., 57, 148.
138. Miller, G., Nepom, G. T., Reich, M. B. and Thomas, J. W. (1993). Autoreactive T cells from a type 1 diabetic recognize multiple class II products. Hum. Immunol., 36. 219-26.
139. Glimcher, L. and Shevach, E. M. (1982). Production of autoreactive I region-restricted T cell hybridomas. J. Exp. Med., 156, 640.
140. k molecule. J Immunol., 134. 1780.
141. Imperiale, M. J., Faherty, D. A., Sproviero, J. F. and Zauderer, M. (1982). Functionally distinct helper T cells enriched under different culture conditions cooperate with different B cells. J Immunol., 129, 1843-8.
142. Wang, Y. and Perkins, D. L. (1991). Characterization of autoreactive T cells: relative importance of self-peptides versus MHC. J. Immunol., 147, 804.
143. French, M. B., Allison, J., Cram, D. S., Thomas, H. E., Dempsey-Collier, M., Silva, A., et al. (1997). Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes, 46, 34-39.
144. Kuglin, B., Gries, F. A. and Kolb, H. (1988). Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes, 37, 130-2.
145. Kuglin, B., Halder, B., Bertrams, J., Gruneklee, D., Gries, F. A. and Kolb, H. (1990). Proinsulin autoantibodies: association with type I diabetes but not with islet cell antibodies, insulin autoantibodies or HLA-DR type. J. Autoimmun., 3, 573-7.
146. Kennedy, G. C., German, M. S. and Rutter, W. J. (1995). The minisatelite in the diabetes susceptibility locus 1DDM2 regulates insulin transcription. Nature Genetics, 9, 293-298.